Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for OCD in Pediatric Bipolar Disorder
NCT00592852Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2005
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluoxetine in obsessive compulsive disorder (OCD), sponsored by Massachusetts General Hospital. Started Dec 2005; status: terminated.
02
Drugs
fluoxetine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00592852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592852.